Table 1.
TEA | IVPCA | P value | |||
---|---|---|---|---|---|
n | % | n | % | ||
Sex | |||||
Male | 24 | 27 | 17 | 19 | 0.667 |
Female | 29 | 33 | 17 | 19 | |
ECOG Performance Status | |||||
0 | 30 | 34 | 20 | 23 | |
1 | 19 | 22 | 13 | 15 | |
2 | 4 | 5 | 1 | 1 | |
Extent of surgery | |||||
Major | 24 | 27 | 6 | 7 | 0.008 |
Minor | 29 | 33 | 28 | 32 | |
Surgical approach | |||||
Open | 42 | 48 | 20 | 23 | 0.040 |
Minimally invasive | 11 | 12 | 14 | 16 | |
Chronic pain preoperatively | |||||
Yes | 8 | 9 | 4 | 5 | 0.660 |
No | 45 | 52 | 30 | 34 | |
Additional non-PCAa IV pain medications | |||||
Yes | 22 | 27 | 24 | 30 | 0.015 |
No | 31 | 30 | 10 | 13 |
IVPCA: intravenous patient-controlled analgesia; ECOG: Eastern Cooperative Oncology Group
14 TEA patients required a PCA for additional pain control